Emotion, Not Fundamentals, Driving This Market<br />By Rev Shark<br />RealMoney.com Contributor<br />11/17/2009 8:23 AM EST<br /><br />When dealing with people, remember you are not dealing with creatures of logic, but creatures of emotion. --Dale Carnegie<br /><br />One of the things that make the market so difficult at times is that forces that drive it often have nothing to do with the fundamentals. We have a particularly good illustration of that right now. This market has been running almost straight up since the first of November not because the economy is recovering so fast or because business is so much better but because the dollar is weak, there is a large amount of liquidity, and too many people are underinvested and trying to catch up as the market flies higher and won't let them in.<br /><br />In the short term, in particular, the market does a very poor job of reflecting the true fundamental situation. Investors never agree as to what the reality of the fundamentals is anyway. On any given day you'll have both bulls and bears with cogent, logical, insightful arguments about why our situation is so wonderful or so ugly. Just because the market isn't listening to one side doesn't mean that side is wrong. It simply means that the market may have other forces at work that are driving it.<br /><br />The great challenge of this market right now is trying to reconcile this amazing bull run since March with the generally held view that we have a tepid economic recovery at best and will face substantial problems down the road as accommodative monetary policy is unwound and we suffer the fallout from a weak dollar. Given the move we have already seen so far this year, it is extremely difficult for many investors to believe that we are still pricing in better fundamentals down the road.<br /><br />The key to navigating this market is to remember that it isn't about the fundamentals but about the emotions. When the emotions become negative, then the bearish fundamental arguments will matter, but for now it is irrelevant how smart or insightful these arguments are. The bulls are in control of the market, and therefore any bearish arguments are irrelevant.<br /><br />Yesterday, well-known bank analyst Meredith Whitney made some negative comments about the market in the last hour and pushed things down. That earned her much criticism for being a grandstander and trying to be sensational. Maybe that's true, but just because the market is ignoring her negative arguments doesn't mean she is wrong. The market just doesn't care about the things she is focused on right now. I assure you, though, that when we see some weak action in this market, the negative arguments she is making now will be cited as the reason for it.<br /><br />Our job is to be aware of the bullish and bearish fundamental arguments and to make sure we stay with the one that is in favor. We might not agree with it, but we have to realize that it is the mood of the market and not the fundamentals that determines whether the pessimists or optimists are in control.<br /><br />It is impossible to predict with any degree of accuracy when the market will shift based upon a fundamental analysis. At this juncture, all we really need to know is that the market is extremely strong. It isn't because fundamentals are so fantastic or the bears so terribly wrong. It is because the psychology is supporting the buyers. At some point it will shift, not because of a change in fundamentals but because of a change in emotions.<br /><br />Early indications this morning are for a little weakness as the dollar bounces back up a little. Overseas markets were mostly down slightly as they digested yesterday's big gains. We have PPI and capacity utilization numbers coming up later this morning, which may cause a jiggle, but for now it looks like we will have a sedate open. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: ZOOM +28.2%, TMI +21.6%, CEU +8.6%, JST +8.4%, EJ +7.7%, SPRD +8.3%, SINA +7.2%, AGO +6.0% (light volume), SKS +4.2%, COV +2.5%, CSIQ +2.1%... M&A news: SMTL +31.0% (Semitool to be acquired by Applied Materials for $11/share in cash)... Other news: NGSX +17.0% (receives FDA approval of Qutenza 8% patch for treatment of postherpetic neuralgia), BPHX +9.9% (awarded a multi-million dollar contract by IBM to modernize mission critical systems of a global tier 1 retail chain), APWR +8.8% (-Power Energy Generation Systems and U.S. Renewable Energy Group announce plans to build wind energy turbine production and assembly plant in U.S.), CSE +7.8% (entered into a definitive agreement to sell substantially all of its healthcare net lease portfolio to Omega Healthcare Investors), NAL +4.4% (Cramer makes positive comments on MadMoney), ONCY +4.1% (collaborators present "positive Phase I/II trial results" in advanced solid Cancers with a focus on the head and neck), DUF +3.0% (Cramer makes positive comments on MadMoney), RSG +2.7% (Berkshire Hathaway discloses new position)... Analyst comments: AIS +6.2% (initiated with Buy at Merriman), PALM +3.3% (upgraded to Buy from Hold at Kaufman Bros), ALKS +2.7% (upgraded to Outperform at Leerink Swann), EAT +1.8% (upgraded to Strong Buy from Outperform at Raymond James).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: PSUN -23.0%, FTK -14.6% (light volume), ADG -14.1% (light volume), JEC -9.9%, AOB -6.8%, CPSL -4.9%, HD -2.4%, TJX -1.8%, BCS -1.7%... Select financial related names showing weakness: IRE -8.5%, AIB -5.7%, CS -1.7%, HBC -1.5%... Select metals/mining names trading lower: AU -3.4%, GFI -2.5%, HMY -2.5%, KGC -2.1%, GOLD -1.9%, IAG -1.8%, RTP -1.7% and BHP -1.2% (Chance of new BHP-Rio bid less than 30%, Liberum Capital says - Reuters.com), ABX -1.6%, NEM -1.5%, EGO -1.3%, GG -1.2%... Other news: CERS -14.1% (Cerus receives FDA Blood Products Advisory Committee guidance for proposed INTERCEPT Blood System Ph. III trial design), PLA -9.6% (Golden Gate Capital is not and will not be involved in any way with any potential acquisition of Playboy Enterprises), SIVB -8.7% (files for $300 mln stock offering), MCHP -7.4% (Atmel Enters into Stipulation to Settle Microchip Offer Shareholder Litigation), SPWRA -6.3% (internal review identifies unsubstantiated accounting entries; also downgraded to Neutral from Overweight at Piper Jaffray, downgraded to Market Perform from Outperform at Raymond James), HOLX -4.3% (Annals of Internal Medicine publishes report recommends against routine breast cancer screening for women under the age of 50), BCRX -4.2% (announces proposed public offering of 5 mln shares of its common stock), ATML -4.1% (Atmel enters into stipulation to settle Microchip Offer Shareholder Litigation), SII -4.1% (announces public offering of 28 mln shares of common stock; downgraded to Neutral from Outperform at Credit Suisse), TGP -2.6% (announces that it prices its public offering of 3.5 mln common units at $24.40/unit), AWK -2.5% (announces 37.4 mln secondary common stock offering), ETN -1.4% (Berkshire Hathawy liquidates position), NVS -1.2% (Novartis Influenza A(H1N1) 2009 vaccine US interim data show lower doses of antigen may suffice)... Analyst comments: ZUMZ -3.9% (downgraded to Neutral from Buy at B. Riley), JOYG -1.9% (downgraded to Neutral at UBS), VRTX -1.2% (downgraded to Neutral at Merriman).